Life Science Success Don Davis PhD, MBA

In this episode of Life Science Success, host Don interviews Dr. Sam Clark, founder and CEO of Terran Biosciences. They talk about Dr. Clark's innovative approach to creating new neuropsychiatric therapeutics and how his personal experiences with mental illness inspired him to enter the biotech industry.
 
The episode also explores various breakthroughs at Terran, including their innovative work with prodrugs, anti-psychotics, and psychedelics, along with their unique, efficient team structure modeled after Silicon Valley tech companies. Additionally, they delve into the inspiration, challenges, and methodologies that drive Terran's mission to provide affordable and modern treatments for patients in need.
 
 
00:00 Introduction to Life Science Success Podcast
00:40 Sponsor Message from D3 Digital Media Marketing
01:21 Guest Introduction: Dr. Sam Clark
02:12 Dr. Clark's Journey into Biotech
04:15 Founding Terran Biosciences
07:13 Innovative Projects at Terran
13:00 Psychedelic Compounds and Patient Use
20:00 Overcoming Barriers in Drug Development
23:57 Leadership and Inspiration
31:09 Conclusion and Final Thoughts

In this episode of Life Science Success, host Don interviews Vance Lyon, an accomplished chemist with a four-decade career in the life sciences industry. Vance discusses his educational background, career journey, and key experiences.
 
The conversation also delves into the vital role of Davos Pharma in providing comprehensive services for biotech companies, including API production, formulation, and IND filings. Vance shares insights on leadership, his inspirations, and concerns, while reflecting on his contributions to significant pharmaceutical projects. Join us for an engaging discussion on life sciences, chemistry, and the intricacies of pharmaceutical development.
 
 
00:00 Introduction to Life Science Success Podcast
00:39 Sponsor Message: D3 Digital Media Marketing
01:22 Meet Vance Lyon: A Journey in Chemistry
02:27 Early Life and Education
07:22 Career Beginnings at Parish Chemical
11:08 Transition to Kemmerer Polytech
12:57 Joining Davos and Key Projects
16:06 Services Provided by Davos
27:34 Leadership and Personal Insights
35:52 Conclusion and Farewell

In this episode of the Life Science Success Podcast, host Don Davis, PhD, MBA, interviews Dr. William Chou of Passage Bio. Dr. Chou discusses his transition from a practicing physician to a leader in biotechnology, reflects on the profound patient relationships he misses, and shares insights into Passage Bio's work on gene therapy for neurodegenerative diseases like Frontotemporal Dementia (FTD). They delve into the progress of their Phase 1/2 clinical study, the urgency of developing treatments for genetic mutations, and the potential impact on patients and their families.
 
Learn about the most recent developments and how Passage Bio is working to give those suffering from these life-threatening conditions hope.
 
00:00 Welcome and Introduction
00:25 William's Journey into Life Sciences
01:30 The Emotional Impact of Leaving Clinical Practice
02:31 Overview of Passage Bio
02:52 Understanding Frontotemporal Dementia (FTD)
06:38 Current Progress and Future Prospects
10:04 The Urgency and Hope for FTD Treatments
11:37 Goals and Closing Remarks

In this episode of the Life Science Success Podcast, Don Davis PhD, MBA interviews Igor Fisch, founder of NewBiologix. Igor shares his journey from academia to entrepreneurship, highlighting his success with Selexis, a company he sold in 2017 that specialized in monoclonal antibodies. He discusses the challenges of gene therapy, specifically the high costs, and NewBiologix's innovative approach to making gene therapy more affordable. Igor also provides insights into the industry's future, emphasizing the significance of stable production platforms for viral particles.
00:00 Introduction and Welcome
00:15 Igor's Journey into Life Sciences
00:37 The Success of Selexis
00:56 Transition to Gene Therapy
03:32 Challenges in Gene Therapy
03:50 The Importance of Stable Platforms
05:11 The Role of Biotech Startups
05:57 Balancing Science and Business
06:51 Networking at BIO Conference
08:14 Future Vision for New Biologics
09:21 Conclusion and Farewell

In this episode of the Life Science Success Podcast, Dean Petkanas, co-founder of Kannalife Sciences, is interviewed at the Bio International Convention in San Diego. Dean shares his journey from investment banking in the 80s to founding Kannalife Sciences in 2009. He discusses the company's focus on developing cannabinoid-based drugs, specifically targeting chemotherapy-induced peripheral neuropathy. The conversation covers the challenges and opportunities in cannabinoid drug development, the importance of targeting specific types of pain, and the current state and future prospects of Kannalife Sciences. Dean also highlights the significance of partnering and collaboration in advancing novel therapeutics.
 
 
 
00:00 Welcome to the Life Science Success Podcast
00:20 Dean's Journey into Life Sciences
01:04 The Evolution of Kannalife Sciences
02:18 Challenges and Opportunities in Cannabinoid-Based Drugs
03:06 Understanding Pain and Neuropathy
06:08 Investment Insights and Market Trends
07:40 Kannalife Sciences's Current Focus and Future Prospects
10:02 The Importance of Partnering at Bio
11:02 Closing Remarks and Future Meetings

 

In this episode of the Life Science Success Podcast, host Don interviews Sean Rothwell, CEO of Evoke Nano, about the company's groundbreaking work in developing EBQ218, a revolutionary nanoparticle-based pulmonary therapeutic. They discuss the efficacy of EBQ218 in treating cystic fibrosis and its potential as a broad-spectrum antibiotic against drug-resistant superbugs. Sean shares insights into the company's journey, their upcoming clinical trials, and the broader impact of their work on patient outcomes in the healthcare landscape. Tune in to learn how Evoke Bio is poised to make a significant difference in combating infectious diseases and improving lives.
 
 
00:00 Welcome and Introduction
00:09 First Impressions of BIO Conference
00:37 Sean's Background and Journey into Life Sciences
01:42 The Science Behind Evoke Nano
02:28 EBQ218: A Revolutionary Pulmonary Therapeutic
04:16 Challenges and Future Pathways
05:24 Investment and Partnership Opportunities
06:42 Broader Applications and Future Vision
08:16 Addressing Drug Resistance and Regulatory Pathways
18:48 Conclusion and Final Thoughts